Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-19-052611

EVP, Chief Commercial Officer bought 5,143 shares at $17.50 ($90,003)

From the SEC's structured data for this filing

Trades in this filing

POYHONEN JOHN · EVP, Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2019-10-03 Purchase : show line 1 in the form +5,143 $17.50 $90,003 18,143 D
Open-market purchases · 5,143 sh · avg $17.50 · $90,003
Loading xslF345X03/doc4.xml…